TREATMENT OF CYSTINURIA WITH BUCILLAMINE

用布西拉明治疗胱氨酸尿症

• 批准号: 3742815
• 负责人: CHARLES YC PAK
• 金额: --
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3742815
• 关键词: aminoacid analog; cysteine; cystinurias; drug adverse effect; drug screening /evaluation; excretion; human subject; human therapy evaluation; immunomodulators; metabolism disorder chemotherapy

The overall goal of this project is to prove that Rimatil (on weight basis) is more effective that Thiola in lowering systine excretion, and that it provides a greater safety of usage in patients with cystinuria.

这个项目的总体目标是证明Rimatil(体重 在降低收缩素排泄方面比Thiola更有效，并且 它为患有半胱氨酸尿症的患者提供了更大的安全性。